+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Migraine - Pipeline Insight, 2025 - Product Thumbnail Image

Migraine - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitochondrial Myopathies- Pipeline Insight, 2025 - Product Thumbnail Image

Mitochondrial Myopathies- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025 - Product Thumbnail Image

Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Multiple System Atrophy- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple System Atrophy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Muscle Spasticity - Pipeline Insight, 2025 - Product Thumbnail Image

Muscle Spasticity - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Progesterone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Progesterone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Tourettes Syndrome Drugs Market 2025-2029 - Product Thumbnail Image

Tourettes Syndrome Drugs Market 2025-2029

  • Report
  • June 2025
  • 197 Pages
  • Global
From
Dravet Syndrome Treatment Market 2025-2029 - Product Thumbnail Image

Dravet Syndrome Treatment Market 2025-2029

  • Report
  • May 2025
  • 222 Pages
  • Global
From
Alzheimers Disease Therapeutics Market 2025-2029 - Product Thumbnail Image

Alzheimers Disease Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 225 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics Market 2025-2029

  • Report
  • April 2025
  • 251 Pages
  • Global
From
Peripheral Neuropathy Treatment Market 2025-2029 - Product Thumbnail Image

Peripheral Neuropathy Treatment Market 2025-2029

  • Report
  • April 2025
  • 233 Pages
  • Global
From
Cannabidiol (CBD) Market 2025-2029 - Product Thumbnail Image

Cannabidiol (CBD) Market 2025-2029

  • Report
  • April 2025
  • 211 Pages
  • Global
From
Botox Market 2025-2029 - Product Thumbnail Image

Botox Market 2025-2029

  • Report
  • March 2025
  • 208 Pages
  • Global
From
Spasticity Treatment Market 2025-2029 - Product Thumbnail Image

Spasticity Treatment Market 2025-2029

  • Report
  • February 2025
  • 247 Pages
  • Global
From
Central Nervous System (CNS) Stimulant Drugs Market 2025-2029 - Product Thumbnail Image

Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

  • Report
  • February 2025
  • 214 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more